Eric Jensen Email & Phone Number

Driving growth of Galleri Multi-Cancer Early Detection (MCED) test through strategic and operational leadership of of the clinic segment.

Served as global, cross-functional strategic leader for Repatha, mapping the growth strategy for one of Amgen's most important assets across all geographical and functional teams

Columbus, Ohio Metropolitan Area

In this diverse role, I supervise a 360-person US primary care sales organization. I also lead 32-member national sales operations team and a team responsible for advancing field capabilities across all products and business units in Amgen’s $17 billion US business. I am really proud of how the team delivered 35% revenue growth in 2021 despite a tough.

Columbus, Ohio Metropolitan Area

I led a team of 6 responsible for marketing strategy for a $500 million portfolio of 12 hematology, oncology, and biosimilar products sold in 34 smaller international markets. We grew sales 25% in 2020 by delivering 20 biosimilar launches, often using creative deal structures to drive market access.

Columbus, Ohio Metropolitan Area

I led a team of 28 responsible for contracting strategy, account management, and demand generation activities across GPOs, IDNs, and oncology clinics for Amgen’s $7 billion US oncology portfolio. We defended Neulasta® against multiple biosimilar competitors with innovative contracting strategies. We also launched MVASI® and KANJINTI® biosimilars; these.

Columbus, Ohio Area

In this role, I led a team of 67 responsible for promoting a $1.5 billion portfolio of Neulasta, XGEVA®, Neupogen®, Prolia®, Vectibix®, Nplate®, Aranesp®, and Imlygic® across the Midwest. My region achieved nation-leading Neulasta OnPro® share of 63% in 2017 with meticulous account segmentation and a white glove service model, combined with team contests.

Thousand Oaks, California, United States

I coordinated strategic and financial planning processes, business reviews, and goal setting for Amgen’s $15 billion US business. I also spearheaded a US restructuring program, building alignment for changes in organizational strategy and design. We cut $175 million from select expense categories, creating capacity to invest in our cardiovascular business.

Thousand Oaks, CA

In this role, I was responsible for incentive compensation plan design, national sales meetings, sales force analytics, and field capabilities for the $8 billion US inflammation and nephrology business unit with a 400-person field force.

Thousand Oaks, CA

I led team of 6 responsible for promotional strategy, as well as sales tools, tactics and training for US launch of Prolia, a buy and bill biologic treatment for osteoporosis. By championing an overhaul of our promotional approach, I helped drive 300% growth in demand. Today, Prolia is a $3.2 billion product.

Thousand Oaks, California, United States

I was responsible for brand positioning and messaging, creative content, and promotional speaker programs for Sensipar®. I contributed to US sales growing from $36 to $412 million in 4 years by collaborating with KOLs and guiding messaging about patient benefits of starting therapy sooner than previous standard of care.

Greater Denver Area

As part of Amgen’s commercial development program, I promoted Enbrel® to dermatologists. I joined in time to launch Enbrel for psoriasis and drove 5x revenue growth and 4x prescriber growth during my 18-month sales rotation.

New York City Metropolitan Area

I supervised team of 2 at this leading advertising agency. Working with the Pfizer account, I coordinated an agency task force that developed the prelaunch strategy for Lyrica®.

New York City Metropolitan Area

At this pioneering healthcare-focused marketing advertising agency, I led an agency team that developed the branding, positioning, and messaging materials for launches of Tamiflu® (Roche) and Vioxx® (Merck).

Master Of Business Administration (Mba)

Bachelor Of Arts (B.A.)